新闻资讯

News Inforamtion

[Good News] Nuoyuan Medical Wins First Prize from the China Invention Association


Release time:

2022-11-09

Recently, the China Invention Association [National Science and Technology Award Certificate No. 0123] awarded the highest prize—the First Prize—of the China Invention Association’s “Invention and Entrepreneurship Award for Innovation” to two organizations and their respective leaders: Professor Zhang Chenping, head of the Ninth People’s Hospital of Shanghai Jiao Tong University, and Chairman Cai Huiming, head of Nanjing Nuoyuan Medical Device Co., Ltd. This award recognizes their outstanding achievements in “the integration and innovation of diagnostic and therapeutic approaches for head and neck malignant tumors.”

  Recently, the China Invention Association [National Science and Technology Award Certificate No. 0123] awarded the highest prize—the First Prize—of the China Invention Association’s “Invention and Entrepreneurship Award for Innovation” to two organizations and their respective leaders: Professor Zhang Chenping, the principal investigator from the Ninth People’s Hospital of Shanghai Jiao Tong University, and Chairman Cai Huiming, the principal investigator from Nanjing Nuoyuan Medical Device Co., Ltd. This award recognizes their outstanding achievements in “the integration and innovation of diagnostic and therapeutic approaches for head and neck malignant tumors.”

  The China Invention Association was established with the joint initiative of Party and state leaders, academicians of the Chinese Academy of Sciences, and social activists, and was approved by the central authorities as a comprehensive, nationwide, non-profit social organization. The “Invention & Entrepreneurship Award—Innovation Award” was approved by the Ministry of Science and Technology in 2005 and set up by the China Invention Association. It is the first national-level award ever established specifically for inventors. The selection process for this award enjoys the support of various government departments and organizations, including the Ministry of Science and Technology, the All-China Federation of Trade Unions, and the National Intellectual Property Administration.

  Receiving the First Prize from the China Invention Association is not only a source of honor but also a profound sense of responsibility for Nuoyuan Medical. Building on the world’s first “Application of Indocyanine Green Fluorescence Imaging Technology in the Treatment of Oral Squamous Cell Carcinoma: A Chinese Expert Consensus,” released at the beginning of this year, the company will continue to provide higher-quality and more advanced technologies and equipment for precision oncology treatment, and will develop industry standards that are uniquely original to China.